Pharmaxis (ASX:PXS) releases “excellent” final set of interim data from phase two cancer trial
Pharmaxis (PXS) has released the final set of interim data from its…
Pharmaxis Ltd (ASX:PXS)
About Pharmaxis Ltd
Key Information
PXS In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 12.50pm 28/11/2023 | Results of Meeting | 353.47KB | 76 |
| 10.47am 28/11/2023 | CEO Presentation to AGM | 1.22MB | 175 |
| 10.40am 28/11/2023 | Chair's Address to Shareholders | 162.83KB | 81 |
| 13/11/2023 | Application for quotation of securities - PXS | 24.91KB | 683 |
| 09/11/2023 | First patient dosed in Phase 2 trial of sleep disorder | 493.58KB | 276 |
| 06/11/2023 | Application for quotation of securities - PXS | 24.91KB | 182 |
| 31/10/2023 | Investor presentation - quarterly update | 576.24KB | 1.9K |
| 31/10/2023 | Price Sensitive PS Quarterly Activities Report | 818.62KB | 190 |